文献速递母胎医学产科

基因测序在识别产前疑似下尿路梗阻的潜在遗传性疾病中的价值

The utility of gene sequencing in identifying an underlying genetic disorder in prenatally suspected lower urinary tract obstruction.
PubMed 文献 · Prenat Diagn · 2023-08-18

该研究为胎儿测序联盟五中心回顾性病例系列,收集产前疑似下尿路梗阻(LUTO)且分子诊断阳性的7例胎儿,分析人口学、超声、基因检测与分娩结局。最终无一例确诊为尿道梗阻即LUTO;5例为膀胱壁平滑肌缺陷(MYOCD 2例、ACTG2 2例、MYH11 1例),2例涉及KMT2D(1例)和BBS10(1例)。作者认为分子诊断对产前疑似LUTO但可能存在非LUTO解释的胎儿有重要价值。

要点

  • 7例产前疑似LUTO且分子诊断阳性者,最终无一例确诊为尿道梗阻即LUTO。
  • 5例为膀胱壁平滑肌缺陷:MYOCD 2例、ACTG2 2例、MYH11 1例。
  • 其他泌尿生殖和/或非泌尿生殖畸形2例,涉及KMT2D 1例和BBS10 1例。

核心结论

  • 作者认为分子诊断在产前疑似LUTO但超声表现可能有非LUTO解释的胎儿检查中有价值。

研究设计与样本

  • 胎儿测序联盟五个中心的回顾性病例系列,收集产前疑似LUTO且分子诊断阳性的病例,共7例。
  • 汇总人口学资料、超声图像、基因检测(含变异分类)及分娩结局。

主要发现

  • 共识别7例产前疑似LUTO且分子诊断阳性的病例,最终无一例确诊为尿道梗阻即LUTO。
  • 5例为累及膀胱壁并干扰膀胱排空的平滑肌缺陷:MYOCD 2例、ACTG2 2例、MYH11 1例。
  • 2例见其他泌尿生殖和/或非泌尿生殖畸形,分别涉及KMT2D 1例和BBS10 1例。
  • 所有变异均分类为可能致病性或致病性。

临床怎么用

  • 作者认为分子诊断在产前疑似LUTO但超声表现可能有非LUTO解释的胎儿检查中有价值。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fetal megacystis generally presents as suspected lower urinary tract obstruction (LUTO), which is associated with severe perinatal morbidity. Genetic etiologies underlying LUTO or a LUTO-like initial presentation are poorly understood. Our objectives are to describe single gene etiologies in fetuses initially ascertained to have suspected LUTO and to elucidate genotype-phenotype correlations. METHODS: A retrospective case series of suspected fetal LUTO positive for a molecular diagnosis was collected from five centers in the Fetal Sequencing Consortium. Demographics, sonograms, genetic testing including variant classification, and delivery outcomes were abstracted. RESULTS: Seven cases of initially prenatally suspected LUTO-positive for a molecular diagnosis were identified. In no case was the final diagnosis established as urethral obstruction that is, LUTO. All variants were classified as likely pathogenic or pathogenic. Smooth muscle deficiencies involving the bladder wall and interfering with bladder emptying were identified in five cases: MYOCD (2), ACTG2 (2), and MYH11 (1). Other genitourinary and/or non-genitourinary malformations were seen in two cases involving KMT2D (1) and BBS10 (1). CONCLUSION: Our series illustrates the value of molecular diagnostics in the workup of fetuses who present with prenatally suspected LUTO but who may have a non-LUTO explanation for their prenatal ultrasound findings.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Brar BK, Blakemore K, Hertenstein C, et al. The utility of gene sequencing in identifying an underlying genetic disorder in prenatally suspected lower urinary tract obstruction. Prenat Diagn. 2023. PMID: 37594370. doi:10.1002/pd.6425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。